{"ticker": {"uuid": "6e12059a-ee92-4d60-a6de-d22ba7fd457f", "symbol": "BIIB", "name": "Biogen Inc.", "exchange": "BUE", "country": "AR", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOVVR5dEN4SnN0MHpFOGNsMUZzWmhwWXpidnl5c0N1c1lTaWNoNTBoeGFNMjZzZ1dfZXdoME5GOUM2eW5SdENiRTVDVElCeG5ZUkJ0NTN4S3plWXhHQ3dHZDRZa0hBdEVtVmlTc0wyS1dhNnVSbFBiZXRJNng4NFBzQWV5ai1SRTg1SUJDaWJNdnQ5NVVv?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T14:51:00+00:00", "published_display": "15 Jul 2026 14:51", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen's incoming legal chief has 20 years in biotech leadership", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOUnRIeGp1NHc0X0U4U29lRGp5UHZBMUJ5NWJIamVEZVNfUjMtZ2FFUHROM0Z3ZlZIajZ1OUh3dXFQZDRkcERVRDJYVnhfYWp2cnNDTVotVE1wdW1BQkhTUk1PV3l2bzQ2akZLSThnVGhfZEY3WnRtRGkzNmUzZ296cE1zRS0wQ2MyZ0Z6QUNxZWpSTG5uelBqc0xVVkpsak9qdzRJNw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:15:00+00:00", "published_display": "15 Jul 2026 12:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AAIC26: Biogen stock drops after unveiling tau-targeting ASO data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQWRsTVNULWt1Y2Q0RVFPNmktOFFFLXhiYkdyeGJLeTBMcDhwMVViMnNjbWFzbF9Yc3lfTnVnVENFeVc4cjNzSmhYMTVsX1lTcFoyNTNVd19YY1BKZDRZSlVJOXdtVEs1dVBSNFY2aUR4R21nY0ZIT0k5a1MzTmIxM0dHbWxTMGRsVmdvWVBkVjhSdE5kbU93UDRuWl9BZXBBNS0tLXdOTHNtdw?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2026-07-15T10:38:07+00:00", "published_display": "15 Jul 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Following Fresh Alzheimer\u2019s Data Is The Upside Story Still Intact", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxONk5GX0ZoNHhUVFNpb0hlRmEyRHY1UC1xUjl2ZFBidUxKNW1zTTRJckdsbzlDMU5VNlNkcHdKM19KcURzMzRDZzU1enJTcEo2ckJRTjhpSERaVmlVWmFYeWlOWVBFSXU5ZFFoSHBCZzhlLXNqYmNKUVBqN2cyQWx1RmdaZmJ3dWhFU3NoZUFfeVFYek5IM3NTS0cxaTRtaGphTl9BVw?oc=5", "source_name": "Market source", "published_at": "2026-07-15T02:11:00+00:00", "published_display": "15 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Dips As Questions Weigh On Alzheimer's 'Breakthrough'", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPVDB3YXIwcWpmMUpkUGJ4bGhQQ05HWjJIZi16RmFLeEN3UW1nTmhmV2RVUjdmWko0VWhwaGlqYXpHbjU2RzdndUdiN2R5UVVxc1VoRXU4YWs1SDZSQnhHUGQyem1xalZiX2RxcGtMU3M4aE9SMnhQQktNMGU4Q2pqRmxPbERDdTYzMC1Bc1hyYklQSGJHNFE?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-07-14T20:13:00+00:00", "published_display": "14 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Alzheimer\u2019s Drug Leaves Questions Unanswered, and That\u2019s a Problem", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFA3VFNGa2ZadVdpZmNTSkdPcy1IdUR3Rl9SOHhEM1VRbTJsVFdfUi1EdUw1Z2IyZ1JyTWtGa0ZZTFU2b3ZueTlISU83NXFReDkwMWVvN2Q5REJKRjdoSUVFc2tNUDg2Y29sWVpCbzVRVXJCb3JhdmhvLVZ3?oc=5", "source_name": "Barron's", "published_at": "2026-07-14T18:09:00+00:00", "published_display": "14 Jul 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen defends anti-tau drug after stock slides on Alzheimer\u2019s readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSW45Q216RDR0VU1LTmgzRXF2M1BEdVExcGZhVDBDWlQzNHVVLXpNYmRtRHFGZkJPZGJxc3gzQkpQSzE1eldnUE5xdGUyMkE4RkxvdEl6aHBfNFMweUV5RTI5OWNzcHNzQUNWNGJLaTRyZllYblBJQmQtZzUzVzh3YWF5Ry1xSjV5azhfNmhoREdVdk8wRk8zaFZTZTZIRUk2Mm5IeUYyYw?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-07-14T18:00:18+00:00", "published_display": "14 Jul 2026 18:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock falls 8% on Alzheimer's drug diranersen trial data", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE4yZE1lckJXYnZXWjd0T2FvU0h6LWNRcEZMUXgtOFRkYktxRFg4NVJqYTJxMjk1eE81b0Z4dW83cDFLN2Fsa1lFLWQ2Q0JHdmg3R0pjZng3a1p2YWZOR0pmSVQwT1N5dHNrbkVkeEMtTnJXalhGUVQ3RlFvMUM?oc=5", "source_name": "qz.com", "published_at": "2026-07-14T17:42:38+00:00", "published_display": "14 Jul 2026 17:42", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen slides as investors reassess Alzheimer\u2019s data and earnings overhang", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZzdxemtVY2FSQXpyalFTX1YxaVpEUE9BOGpvR2xQN2MtcXRrcVQ4eVRLcjE3eXZfd05WRTd2aWxtMlQ2R3ZwVUczWm1VcnFEdnlfX3ZvNEpfNk56Y19BaWlGNnhubmV2TVdTZXNCQ3BHdHFSdEh5R1FFRzNWY29IUWxZMXJlM0JiUHNVMnNxcVdXVWxPSE50ZVpzVHVIanJEMXZfd0dBcE9IeTJUcElOWVhMdkdmUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T14:51:00+00:00", "published_display": "14 Jul 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Biogen (BIIB) At-Home LEQEMBI Autoinjector Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOVUZIWjNnSWJNTFFlaGlKTmh2LVp5ZjlSM0t0TE1ORFVjYVFXalN0V2NuWEIxcHNfMXllbFpNeDFTeVBVWmZTQ1pGUFhnV3M5R01GbU80NFRCdVlaQVJHcUtlNUkyYXlhRmJEdGxpaG9pRGVNZ1V0czUycE9JWmU0M3BDRml0N1VZNlJoSGhxR2VmWmlWS0EtalUtbVI?oc=5", "source_name": "Market source", "published_at": "2026-07-14T14:14:39+00:00", "published_display": "14 Jul 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Shares Rise After Positive Phase 2 Alzheimer\u2019s Trial Results (BIIB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQLWpoTm14djJ1V2JHV1hxQlNoZUwtRjV0V2pOOFBIb2haNEU4TW5QdUg5TUhQb180bWxFczdYcWZScHF2Yk4zVHVIYUlIY3Q2Y2VHamJQWnl6QVh1YnVvb2JUNXFvSW4taTRvWl9jR3BMY0JiRjNYQWMyT3VSUnBhSkl5S05TeUhteTdialVBdl9CbFF3b0ZxVkxR?oc=5", "source_name": "Market source", "published_at": "2026-07-14T13:48:37+00:00", "published_display": "14 Jul 2026 13:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer\u2019s Drug Study Details", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxONlozWDZQcXFxdjFmVEJvWEE2M0p4OUFKX2FsOEFSalB1RnRsVXFxa0dSenNGMmFaMzQxakRFQVB0eERMXzU4UlVpNkQ1WWRzc0hDZk9WQ1o4NkhlUlBhUVZkMm85Wl9TMGM2T3lCeEdUekVJUHZ0Z2t5WGh3V0FqRjgzbw?oc=5", "source_name": "Barron's", "published_at": "2026-07-13T18:32:00+00:00", "published_display": "13 Jul 2026 18:32", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNR1huQlhQV3dTUFFGeXMxMFBOVkc3aXhaYUhscUhUdE9UQTRSVk9CNGtDRGFhcTQyYlowbXdiNUR2RGdDczNMZXdwblR5OFdNNk04cjRLUkR3cXN4MXhKVG1RWXYtT1NTb2V6d2JiMzF6dndGX194alkwZGw4UjdubUxkWXpuM0E1MEZIVXo3SlFvWlE?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Moves 7.0% Higher: Will This Strength Last?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNOWxoSkkwTG5iTlF2cEhMNDZLU3JBdjZ3UVZtMVE4SW5scE9tNmNQQUx6MmJyWGJSMDI4bjh1NFhBUzE5OHRJRmRScUs1TkxBSHJFamo1MFNOWFJjVFRlMTdIYkRHSFRpei0zTExuMGhSNG9ZTXo4dUJ6VUR1YTFOOEt6VlNnOHptc21ITEFwWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Biogen (BIIB) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbmNGeFAtenBxazFmYWJoYzFSd2tSRDRHa3J2S1F6SVdKRkFxTzY1WlFxeFg0TV9VYzBBdk54MmtBUFhNY211enhVSGUxeTczMURlUEktTmVpLUVDUUFDRzNBT2pWUFdVRUlCT3U0VHVfYjMxZUs1bW4xeWJTU2hXUURrTG9EaGdnbGU4N0hJNHVxb3l5UUFn?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock price forecast: $174.41 support comes into view as BIIB slips 1.94%", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQamVtNDJibjVtbWNGNEdPWG1QajFFcUR6cmlUYWNRWmQzUnRaMHd2WFNmYlZDSGN0b011SHlqUG1rN25sSmlfWTRTeXM0Q1RHTXVBZGtMbC1ab1NOSGRvdlp4VlJrMjU0ZUFObTlTMFM4SVlxbjZYSFVycFlpOFlRb2R6d0lac2pXTHE2T3RwRmlOOEp5cGNCTnZfeExudw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Stock Could Be 10.3% Undervalued on Its Pipeline Narrative", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNdVlTVFE5VWtlZDZCV1lvVU5sMzV5QUc1UW8tMEFITTR6SkxKZmpSYjVWaXpaeHNNLXJFcXVpeGpiVXhOZXBHQlZVZlNJMXR1UFFLYW9mUG9jajJUZXE4cWhybGZ6Nm1DZ0x2ZVFEb0d2eFByWTl5VUZicTN4SVlhVWdpdmNGZE5WYXRqRDYwU3FUWUdReXc?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNc0RqN0ZqUGNwMHBUdDhPcDlKYkdpWG5vc3ZfVUpQckMxbVdLLUhQVi1SMUlXRlpCMGZGb013VEJzcUdldi1sTzkwcFh3ZE03aDFsakIwWXlGbGxLRXhBVUxoQzRVN3BNekY1UTR2QmdzMXpLa01Mc0dVcXRlSUpQV0lta0hDVXc4cFM0eWxwV0tOdkV2ZU1XTWVrQ1U2LTdGTmlQNWQtZlNaNTQ1N2lQTEtmRlhzek1EblhUMlhqS3VTTWc?oc=5", "source_name": "Biogen", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Apellis Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ256enZtNjcySFlVRFVBdlVmVlIxLVFUYVZGVVJCMWJyaEVwaG1XSFdrOWxZU3ZDWGtiZmVUNkRtSmtKeTIyaldoQ2xuQ3JzaXdQeUNteGZOM3hZYzI5UUJ0MXVYNDBjVGZrSldQQUFSaF9MUUphR1lyX3daMl9pODJkdGU1NWRLM0NLRDlvelJmOEkzYV92VkY1TE1qWEFXV3dyWW1FeGJObnowT0VfUlRISFR0YXc?oc=5", "source_name": "Biogen", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Participate in the Bank of America Securities 2026 Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPV09Ub1IzblUzZVVHM2NaZHFOMFB4TEZuYXhlZG9FUENtUG94MXVpdkc5SjF3TEt5bk1ZTmh6cHNvWEgtb0NjS2xvcVZSQ09HTmtmQmRLNXkwRVVNUlBCWldteHdTc0lsOW1MMl9JLUlwRTFUMXpHQV9nU2RSNDFpNDgxSGFGTmdZTWR1TnB1T3pKWWhfU3ZVTU1RQzd3WkE4NV9KSGV2YTRXY0lmNlY1M0xpNGlqWmZYVlN1dW02bmk?oc=5", "source_name": "Biogen", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Apellis, Enhancing the Company\u2019s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOVEV0VlhLbzVMaGdWYjJJLVN4V0NIVnVidDk2NW9vRzVpTTNwVDBZTl9aQW9Xd0FKQ3JTeXBvcUZpSTFQNHEwN3NRX1FTeUdfdVNlYWpDZlREb1lOd0RVemRNUG5WRnlHN3R1czVXN2NteVFqeV9hYzZybXZZWVkwTDZSNlFrQmJtNFBOUjZqZU9jRXFRRmFhNE1oNkVfM1ZrWEFIZ2FQclpuYmRYV09jVDdGSDZKZ1BPYnhXZHNIZw?oc=5", "source_name": "Biogen", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Alcyone Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNOGRybmhqVmpTUUxzQ2xtbEllRDNCdjdyREVVbjdyUEp1XzFaVl9zaFN2TUV2b1YtQXZLY0p2Ulc0eG9BaE9ZdDJ3SlJFVUczMzJMYXZFRHlmMlF1cG42V1RIY0ZLNmI4N2pIVFRLc2VLSGxrX0JVNGVybF9XRV9ZZFdMZXMtS3JNNGh4X3FqdDFqUUxLSWkzYTJiZFh0T3ItaTMxWGRmV0JSSUpKcWxoYjhnbw?oc=5", "source_name": "Biogen", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOVldHdlEtSGQ4SUFJWUhRT00tT05IT3Y4S3hkOFJrME03R2ZmQ0tiSFhJWFBzaG5NUnctVlZhYy0tNTZGb0dMVDRYOW1BTVBiN1VueU85VTljcEZnUVZfSFIzUnBBVHRydXNpbmY1aUl6WVU1SmVaa3J3cU1sOG5aRXJqbHJNeUQySGpPbGliZ1lxa00tX3dER3c4U3NRZmc5QXZfUDNMRGhVZFQ1R3N1OVRyX1RUUU1aaXQxQkd5Wmt4TU5X?oc=5", "source_name": "Biogen", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPSFNzd2lxZzktOERtU2RYZ0dRNEdMQnhoNzVZR01UeDVYWGk5SWlaV0x2STlzcEdGUmE2Zk5MOWFzS1JfMGRSS0RIM2FxUUowemJJbEFPdFVocjFuVG9hdFRrNEpPZTZqZjhXeWZlYXpaVXp0SUFlRXBUdVVpWUVybm05eWtueHJYemxOT2czWk9iY3UzcUsxSkxpLW53a3ItdDFUQkZteTFXLUJuWFY4czNhUzQ2ZmhvQXhGV1RzM0VlSnB5Vkpz?oc=5", "source_name": "Biogen", "published_at": "2025-08-11T07:00:00+00:00", "published_display": "11 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNVUxBUmhVNXg4eEJUeXFYeW0yMjNDSWxRSktnMzRjTldpbHVWYm1Oa3pFZUthbmtzWi1mZDFaY1dzWXhFQ3RQZkc2TWNTLTMxd1hEZmQ5MlBNWHl2ZzhINHdIanE1c2RxZi0yTEdxd2NRUUJjSms3bDF2WXpTUllPN3p5T3MwOWZKcGpFdkZ3MEpCUTdyeHRQUG9lYk1wWFVmTnJBYWNNTTNOVUE5MXZnYVNNc21lVXFBM2dqeTB4SDdEeUU?oc=5", "source_name": "Biogen", "published_at": "2025-02-18T08:00:00+00:00", "published_display": "18 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQUJPYXk0Y3dERjAxRVRmYVdvV1ZOSVRTYXI2eTgxOVVRWjdPUlNnZy1UanR3MldJN1d3TVEwOFR4SWkwaEJRZmpoOGtSN09iMmdvYjZkSk4zRVJBQXFNaFdOeG5QWm8yLVlhOEVpQmRiaHY5WkJ2akx6d0FFaVZKelZKT3ZIM2hibzNGWkNiQXcxWlAzci1nN2hOdnQ4dC1JNDNsRzktZEFQUW9PdmVBakM3SlA?oc=5", "source_name": "Biogen", "published_at": "2023-09-26T07:00:00+00:00", "published_display": "26 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPLW5Vbmd0c1FZbTd4MzduTnlKa19DS0tNRzlBRjlxMGhqdlhkNm5XUGFTcExGS2JDcHQyTmtQNk5OOGFIYkF5RFFwbXNOSWhRNmh2eW44TzhBNXdRZlVLOUZrb2p6c0VDQ2hqQzZvbUlQOFVCejRsNEd3MXpmQVlMcExFT3NtdnB1cFJjZDRBdTEwa2Y5c1ZLTURlczJFbVJaQVE?oc=5", "source_name": "Biogen", "published_at": "2023-07-28T07:00:00+00:00", "published_display": "28 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental Biologics License Application for the Potential Traditional Approval of LEQEMBI in Early Alzheimer\u2019s Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTUlIb3NucjNtT2VWMkdlUWJPS2I5cDdGVk00LVNJaUxmcTdBd3dFU0VmeENPMlhDdzZWYWwxSGlOQXNpd3QtLVlpNW1jcFlyR1pVekRkLTdyT2VLX1BrdmRRdncxNXRsM0QxVWxyb3RldlZZMm1YTUpaVndtbWtITjBmRU9ZOGRtaG5SSUQwYjRpR0RUQjU2NWZDQmdMZFk1MEVRUnVqclQ2TTdLTnFXT3htODNEQmx2bjhaTHNvMWxuS002SXc?oc=5", "source_name": "Biogen", "published_at": "2023-06-09T07:00:00+00:00", "published_display": "09 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOX01BMWpxUHpWYmFRQTN3U016ZEhjUFQ1UmdDeVR6MHJER0VvNnZIMkw1TXhuWjRaX1JqamxZeFVqeDk1QWgyamFsdUhBb2VpMmhUeWVyQmRIYVNkR2ZOLUpCYU83RXh2U0hhMkhYZy1vS21LSVJncllnZjVXSHd6Mm1EVGZOUDhpNkhveHFyLTZqNHlZYmwtVXBJYWRJQmFnaHdxcW9ZVUFqX3pNSFlBY3RhQVdrZ1pybnNHYUktNUZJQQ?oc=5", "source_name": "Biogen", "published_at": "2022-01-27T08:00:00+00:00", "published_display": "27 Jan 2022 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQQUlSWmZWUV9mYktRV081cXN6c1BRVmxjbXRRSEQ1MTd2SnlCZERDNVFXZGtnQlpMb3B0MHJqRzYtcjVROEczRGRtQUZMMm56TFlQdFVNWnpwVEFuUm9CU1MyUlJvcGR5dHdPQUdjVWIwQmd5d1A3TXQ3dlNabXN2U2VkSGZJMWx2bUt4RHhkWnRPc1ZPeDYydEtlOUplZUg4SEhNd3N5WWk3eXc3M0YtcVl5WHlrM3pOZFN2dHkwaw?oc=5", "source_name": "Biogen", "published_at": "2020-11-27T08:00:00+00:00", "published_display": "27 Nov 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Denali to Collaborate on LRRK2 Program for Parkinson\u2019s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOc0ExWGhSR2pRdzZJU29IcWJvelIwSmRmamM1NFJyMWRKQThhVkVrQXQ1WWpMSHFNSGNKM2lqcmJ0RjkxRzVCNnNIQW1ZZHVWZXA0WEpJTUhwZFFWNzNTN2lneElHYlVYalZuM200WUVELVZiZTJFdEtMd1V3WTZZRERQTlZlRG9neGdXNWl6S0ZhY001Y3cxLXNSQUR4VkFtbVZEMHI3aF9UMGU2Z0hDWE80SmlUOXJrZ0x5OW1sbE9wUi1H?oc=5", "source_name": "Biogen", "published_at": "2020-08-06T07:00:00+00:00", "published_display": "06 Aug 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Board of Directors Approves Separation of Bioverativ and Declares Special Dividend Distribution of Bioverativ Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZXh4dlJwdnhYS3pNay02VWZaYXNqbm1Lamx2NFIxbVhPelI3WVNzeVJJa3RJZU45UllHYUhjMGtqcmgyMUZzZ0pkRzJlVFlOTTl2WVNzcjVfb3JGcnAyWWpSODg4dFUyMmthZU1xMGdJWlAxRWhISzgtZDVIaGRRc1Q0cHhBeHJJYVJURThvQlV0RV8yWmh4QjluN3ZEZnNNeXhvR3BScy1kSnR5UmN0Vk93S3ljek5scmY2ZkV5TQ?oc=5", "source_name": "Biogen", "published_at": "2019-06-12T10:45:37+00:00", "published_display": "12 Jun 2019 10:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Inc (BIIB) Stock Price, Trades & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1ncXJveXZYNmh6cWN1RXNLQXdoNVdoLTluTnhOb0lWbHVVdWZxVWx0OTRkZzVkczRNbFBJUEg1VF85dC1iYVhUazBsVVZfRkV0Q25tenF0RQ?oc=5", "source_name": "GuruFocus", "published_at": "2019-04-15T16:19:17+00:00", "published_display": "15 Apr 2019 16:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Separation of Global Hemophilia Business, Bioverativ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOc1o0UnRZTHRidWIzVGxrNThyZE95WXVtUXVOUVlLT2dQV3hPaG4ta2hzTm1qX1lBZTZyRmRnTmxNaDN6eWdkVExWVVNFMWo2eVZULTdTMHBXUW45Tnd3YkQwdmpJc0VkWUFuRHQ3TzJDNDZJNlZ0Y25HazZVVXludWY0aUgtWWxPQ3h4dWIyNjR0a2V1MTM4RDh0b1JZQW1qU254X0txeDJjZlo3Y0twQXN0dFk4SDVnLWc?oc=5", "source_name": "Biogen", "published_at": "2017-02-01T08:00:00+00:00", "published_display": "01 Feb 2017 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOVVR5dEN4SnN0MHpFOGNsMUZzWmhwWXpidnl5c0N1c1lTaWNoNTBoeGFNMjZzZ1dfZXdoME5GOUM2eW5SdENiRTVDVElCeG5ZUkJ0NTN4S3plWXhHQ3dHZDRZa0hBdEVtVmlTc0wyS1dhNnVSbFBiZXRJNng4NFBzQWV5ai1SRTg1SUJDaWJNdnQ5NVVv?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T14:51:00+00:00", "published_display": "15 Jul 2026 14:51", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen's incoming legal chief has 20 years in biotech leadership", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOUnRIeGp1NHc0X0U4U29lRGp5UHZBMUJ5NWJIamVEZVNfUjMtZ2FFUHROM0Z3ZlZIajZ1OUh3dXFQZDRkcERVRDJYVnhfYWp2cnNDTVotVE1wdW1BQkhTUk1PV3l2bzQ2akZLSThnVGhfZEY3WnRtRGkzNmUzZ296cE1zRS0wQ2MyZ0Z6QUNxZWpSTG5uelBqc0xVVkpsak9qdzRJNw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:15:00+00:00", "published_display": "15 Jul 2026 12:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AAIC26: Biogen stock drops after unveiling tau-targeting ASO data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQWRsTVNULWt1Y2Q0RVFPNmktOFFFLXhiYkdyeGJLeTBMcDhwMVViMnNjbWFzbF9Yc3lfTnVnVENFeVc4cjNzSmhYMTVsX1lTcFoyNTNVd19YY1BKZDRZSlVJOXdtVEs1dVBSNFY2aUR4R21nY0ZIT0k5a1MzTmIxM0dHbWxTMGRsVmdvWVBkVjhSdE5kbU93UDRuWl9BZXBBNS0tLXdOTHNtdw?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2026-07-15T10:38:07+00:00", "published_display": "15 Jul 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Following Fresh Alzheimer\u2019s Data Is The Upside Story Still Intact", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxONk5GX0ZoNHhUVFNpb0hlRmEyRHY1UC1xUjl2ZFBidUxKNW1zTTRJckdsbzlDMU5VNlNkcHdKM19KcURzMzRDZzU1enJTcEo2ckJRTjhpSERaVmlVWmFYeWlOWVBFSXU5ZFFoSHBCZzhlLXNqYmNKUVBqN2cyQWx1RmdaZmJ3dWhFU3NoZUFfeVFYek5IM3NTS0cxaTRtaGphTl9BVw?oc=5", "source_name": "Market source", "published_at": "2026-07-15T02:11:00+00:00", "published_display": "15 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Dips As Questions Weigh On Alzheimer's 'Breakthrough'", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPVDB3YXIwcWpmMUpkUGJ4bGhQQ05HWjJIZi16RmFLeEN3UW1nTmhmV2RVUjdmWko0VWhwaGlqYXpHbjU2RzdndUdiN2R5UVVxc1VoRXU4YWs1SDZSQnhHUGQyem1xalZiX2RxcGtMU3M4aE9SMnhQQktNMGU4Q2pqRmxPbERDdTYzMC1Bc1hyYklQSGJHNFE?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-07-14T20:13:00+00:00", "published_display": "14 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Alzheimer\u2019s Drug Leaves Questions Unanswered, and That\u2019s a Problem", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFA3VFNGa2ZadVdpZmNTSkdPcy1IdUR3Rl9SOHhEM1VRbTJsVFdfUi1EdUw1Z2IyZ1JyTWtGa0ZZTFU2b3ZueTlISU83NXFReDkwMWVvN2Q5REJKRjdoSUVFc2tNUDg2Y29sWVpCbzVRVXJCb3JhdmhvLVZ3?oc=5", "source_name": "Barron's", "published_at": "2026-07-14T18:09:00+00:00", "published_display": "14 Jul 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen defends anti-tau drug after stock slides on Alzheimer\u2019s readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSW45Q216RDR0VU1LTmgzRXF2M1BEdVExcGZhVDBDWlQzNHVVLXpNYmRtRHFGZkJPZGJxc3gzQkpQSzE1eldnUE5xdGUyMkE4RkxvdEl6aHBfNFMweUV5RTI5OWNzcHNzQUNWNGJLaTRyZllYblBJQmQtZzUzVzh3YWF5Ry1xSjV5azhfNmhoREdVdk8wRk8zaFZTZTZIRUk2Mm5IeUYyYw?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-07-14T18:00:18+00:00", "published_display": "14 Jul 2026 18:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock falls 8% on Alzheimer's drug diranersen trial data", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE4yZE1lckJXYnZXWjd0T2FvU0h6LWNRcEZMUXgtOFRkYktxRFg4NVJqYTJxMjk1eE81b0Z4dW83cDFLN2Fsa1lFLWQ2Q0JHdmg3R0pjZng3a1p2YWZOR0pmSVQwT1N5dHNrbkVkeEMtTnJXalhGUVQ3RlFvMUM?oc=5", "source_name": "qz.com", "published_at": "2026-07-14T17:42:38+00:00", "published_display": "14 Jul 2026 17:42", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen slides as investors reassess Alzheimer\u2019s data and earnings overhang", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZzdxemtVY2FSQXpyalFTX1YxaVpEUE9BOGpvR2xQN2MtcXRrcVQ4eVRLcjE3eXZfd05WRTd2aWxtMlQ2R3ZwVUczWm1VcnFEdnlfX3ZvNEpfNk56Y19BaWlGNnhubmV2TVdTZXNCQ3BHdHFSdEh5R1FFRzNWY29IUWxZMXJlM0JiUHNVMnNxcVdXVWxPSE50ZVpzVHVIanJEMXZfd0dBcE9IeTJUcElOWVhMdkdmUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T14:51:00+00:00", "published_display": "14 Jul 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Biogen (BIIB) At-Home LEQEMBI Autoinjector Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOVUZIWjNnSWJNTFFlaGlKTmh2LVp5ZjlSM0t0TE1ORFVjYVFXalN0V2NuWEIxcHNfMXllbFpNeDFTeVBVWmZTQ1pGUFhnV3M5R01GbU80NFRCdVlaQVJHcUtlNUkyYXlhRmJEdGxpaG9pRGVNZ1V0czUycE9JWmU0M3BDRml0N1VZNlJoSGhxR2VmWmlWS0EtalUtbVI?oc=5", "source_name": "Market source", "published_at": "2026-07-14T14:14:39+00:00", "published_display": "14 Jul 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Shares Rise After Positive Phase 2 Alzheimer\u2019s Trial Results (BIIB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQLWpoTm14djJ1V2JHV1hxQlNoZUwtRjV0V2pOOFBIb2haNEU4TW5QdUg5TUhQb180bWxFczdYcWZScHF2Yk4zVHVIYUlIY3Q2Y2VHamJQWnl6QVh1YnVvb2JUNXFvSW4taTRvWl9jR3BMY0JiRjNYQWMyT3VSUnBhSkl5S05TeUhteTdialVBdl9CbFF3b0ZxVkxR?oc=5", "source_name": "Market source", "published_at": "2026-07-14T13:48:37+00:00", "published_display": "14 Jul 2026 13:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer\u2019s Drug Study Details", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxONlozWDZQcXFxdjFmVEJvWEE2M0p4OUFKX2FsOEFSalB1RnRsVXFxa0dSenNGMmFaMzQxakRFQVB0eERMXzU4UlVpNkQ1WWRzc0hDZk9WQ1o4NkhlUlBhUVZkMm85Wl9TMGM2T3lCeEdUekVJUHZ0Z2t5WGh3V0FqRjgzbw?oc=5", "source_name": "Barron's", "published_at": "2026-07-13T18:32:00+00:00", "published_display": "13 Jul 2026 18:32", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNR1huQlhQV3dTUFFGeXMxMFBOVkc3aXhaYUhscUhUdE9UQTRSVk9CNGtDRGFhcTQyYlowbXdiNUR2RGdDczNMZXdwblR5OFdNNk04cjRLUkR3cXN4MXhKVG1RWXYtT1NTb2V6d2JiMzF6dndGX194alkwZGw4UjdubUxkWXpuM0E1MEZIVXo3SlFvWlE?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Moves 7.0% Higher: Will This Strength Last?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNOWxoSkkwTG5iTlF2cEhMNDZLU3JBdjZ3UVZtMVE4SW5scE9tNmNQQUx6MmJyWGJSMDI4bjh1NFhBUzE5OHRJRmRScUs1TkxBSHJFamo1MFNOWFJjVFRlMTdIYkRHSFRpei0zTExuMGhSNG9ZTXo4dUJ6VUR1YTFOOEt6VlNnOHptc21ITEFwWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Biogen (BIIB) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbmNGeFAtenBxazFmYWJoYzFSd2tSRDRHa3J2S1F6SVdKRkFxTzY1WlFxeFg0TV9VYzBBdk54MmtBUFhNY211enhVSGUxeTczMURlUEktTmVpLUVDUUFDRzNBT2pWUFdVRUlCT3U0VHVfYjMxZUs1bW4xeWJTU2hXUURrTG9EaGdnbGU4N0hJNHVxb3l5UUFn?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock price forecast: $174.41 support comes into view as BIIB slips 1.94%", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQamVtNDJibjVtbWNGNEdPWG1QajFFcUR6cmlUYWNRWmQzUnRaMHd2WFNmYlZDSGN0b011SHlqUG1rN25sSmlfWTRTeXM0Q1RHTXVBZGtMbC1ab1NOSGRvdlp4VlJrMjU0ZUFObTlTMFM4SVlxbjZYSFVycFlpOFlRb2R6d0lac2pXTHE2T3RwRmlOOEp5cGNCTnZfeExudw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Stock Could Be 10.3% Undervalued on Its Pipeline Narrative", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNdVlTVFE5VWtlZDZCV1lvVU5sMzV5QUc1UW8tMEFITTR6SkxKZmpSYjVWaXpaeHNNLXJFcXVpeGpiVXhOZXBHQlZVZlNJMXR1UFFLYW9mUG9jajJUZXE4cWhybGZ6Nm1DZ0x2ZVFEb0d2eFByWTl5VUZicTN4SVlhVWdpdmNGZE5WYXRqRDYwU3FUWUdReXc?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNc0RqN0ZqUGNwMHBUdDhPcDlKYkdpWG5vc3ZfVUpQckMxbVdLLUhQVi1SMUlXRlpCMGZGb013VEJzcUdldi1sTzkwcFh3ZE03aDFsakIwWXlGbGxLRXhBVUxoQzRVN3BNekY1UTR2QmdzMXpLa01Mc0dVcXRlSUpQV0lta0hDVXc4cFM0eWxwV0tOdkV2ZU1XTWVrQ1U2LTdGTmlQNWQtZlNaNTQ1N2lQTEtmRlhzek1EblhUMlhqS3VTTWc?oc=5", "source_name": "Biogen", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Apellis Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ256enZtNjcySFlVRFVBdlVmVlIxLVFUYVZGVVJCMWJyaEVwaG1XSFdrOWxZU3ZDWGtiZmVUNkRtSmtKeTIyaldoQ2xuQ3JzaXdQeUNteGZOM3hZYzI5UUJ0MXVYNDBjVGZrSldQQUFSaF9MUUphR1lyX3daMl9pODJkdGU1NWRLM0NLRDlvelJmOEkzYV92VkY1TE1qWEFXV3dyWW1FeGJObnowT0VfUlRISFR0YXc?oc=5", "source_name": "Biogen", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Participate in the Bank of America Securities 2026 Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPV09Ub1IzblUzZVVHM2NaZHFOMFB4TEZuYXhlZG9FUENtUG94MXVpdkc5SjF3TEt5bk1ZTmh6cHNvWEgtb0NjS2xvcVZSQ09HTmtmQmRLNXkwRVVNUlBCWldteHdTc0lsOW1MMl9JLUlwRTFUMXpHQV9nU2RSNDFpNDgxSGFGTmdZTWR1TnB1T3pKWWhfU3ZVTU1RQzd3WkE4NV9KSGV2YTRXY0lmNlY1M0xpNGlqWmZYVlN1dW02bmk?oc=5", "source_name": "Biogen", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Apellis, Enhancing the Company\u2019s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOVEV0VlhLbzVMaGdWYjJJLVN4V0NIVnVidDk2NW9vRzVpTTNwVDBZTl9aQW9Xd0FKQ3JTeXBvcUZpSTFQNHEwN3NRX1FTeUdfdVNlYWpDZlREb1lOd0RVemRNUG5WRnlHN3R1czVXN2NteVFqeV9hYzZybXZZWVkwTDZSNlFrQmJtNFBOUjZqZU9jRXFRRmFhNE1oNkVfM1ZrWEFIZ2FQclpuYmRYV09jVDdGSDZKZ1BPYnhXZHNIZw?oc=5", "source_name": "Biogen", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Alcyone Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNOGRybmhqVmpTUUxzQ2xtbEllRDNCdjdyREVVbjdyUEp1XzFaVl9zaFN2TUV2b1YtQXZLY0p2Ulc0eG9BaE9ZdDJ3SlJFVUczMzJMYXZFRHlmMlF1cG42V1RIY0ZLNmI4N2pIVFRLc2VLSGxrX0JVNGVybF9XRV9ZZFdMZXMtS3JNNGh4X3FqdDFqUUxLSWkzYTJiZFh0T3ItaTMxWGRmV0JSSUpKcWxoYjhnbw?oc=5", "source_name": "Biogen", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOVldHdlEtSGQ4SUFJWUhRT00tT05IT3Y4S3hkOFJrME03R2ZmQ0tiSFhJWFBzaG5NUnctVlZhYy0tNTZGb0dMVDRYOW1BTVBiN1VueU85VTljcEZnUVZfSFIzUnBBVHRydXNpbmY1aUl6WVU1SmVaa3J3cU1sOG5aRXJqbHJNeUQySGpPbGliZ1lxa00tX3dER3c4U3NRZmc5QXZfUDNMRGhVZFQ1R3N1OVRyX1RUUU1aaXQxQkd5Wmt4TU5X?oc=5", "source_name": "Biogen", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPSFNzd2lxZzktOERtU2RYZ0dRNEdMQnhoNzVZR01UeDVYWGk5SWlaV0x2STlzcEdGUmE2Zk5MOWFzS1JfMGRSS0RIM2FxUUowemJJbEFPdFVocjFuVG9hdFRrNEpPZTZqZjhXeWZlYXpaVXp0SUFlRXBUdVVpWUVybm05eWtueHJYemxOT2czWk9iY3UzcUsxSkxpLW53a3ItdDFUQkZteTFXLUJuWFY4czNhUzQ2ZmhvQXhGV1RzM0VlSnB5Vkpz?oc=5", "source_name": "Biogen", "published_at": "2025-08-11T07:00:00+00:00", "published_display": "11 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNVUxBUmhVNXg4eEJUeXFYeW0yMjNDSWxRSktnMzRjTldpbHVWYm1Oa3pFZUthbmtzWi1mZDFaY1dzWXhFQ3RQZkc2TWNTLTMxd1hEZmQ5MlBNWHl2ZzhINHdIanE1c2RxZi0yTEdxd2NRUUJjSms3bDF2WXpTUllPN3p5T3MwOWZKcGpFdkZ3MEpCUTdyeHRQUG9lYk1wWFVmTnJBYWNNTTNOVUE5MXZnYVNNc21lVXFBM2dqeTB4SDdEeUU?oc=5", "source_name": "Biogen", "published_at": "2025-02-18T08:00:00+00:00", "published_display": "18 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQUJPYXk0Y3dERjAxRVRmYVdvV1ZOSVRTYXI2eTgxOVVRWjdPUlNnZy1UanR3MldJN1d3TVEwOFR4SWkwaEJRZmpoOGtSN09iMmdvYjZkSk4zRVJBQXFNaFdOeG5QWm8yLVlhOEVpQmRiaHY5WkJ2akx6d0FFaVZKelZKT3ZIM2hibzNGWkNiQXcxWlAzci1nN2hOdnQ4dC1JNDNsRzktZEFQUW9PdmVBakM3SlA?oc=5", "source_name": "Biogen", "published_at": "2023-09-26T07:00:00+00:00", "published_display": "26 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPLW5Vbmd0c1FZbTd4MzduTnlKa19DS0tNRzlBRjlxMGhqdlhkNm5XUGFTcExGS2JDcHQyTmtQNk5OOGFIYkF5RFFwbXNOSWhRNmh2eW44TzhBNXdRZlVLOUZrb2p6c0VDQ2hqQzZvbUlQOFVCejRsNEd3MXpmQVlMcExFT3NtdnB1cFJjZDRBdTEwa2Y5c1ZLTURlczJFbVJaQVE?oc=5", "source_name": "Biogen", "published_at": "2023-07-28T07:00:00+00:00", "published_display": "28 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental Biologics License Application for the Potential Traditional Approval of LEQEMBI in Early Alzheimer\u2019s Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTUlIb3NucjNtT2VWMkdlUWJPS2I5cDdGVk00LVNJaUxmcTdBd3dFU0VmeENPMlhDdzZWYWwxSGlOQXNpd3QtLVlpNW1jcFlyR1pVekRkLTdyT2VLX1BrdmRRdncxNXRsM0QxVWxyb3RldlZZMm1YTUpaVndtbWtITjBmRU9ZOGRtaG5SSUQwYjRpR0RUQjU2NWZDQmdMZFk1MEVRUnVqclQ2TTdLTnFXT3htODNEQmx2bjhaTHNvMWxuS002SXc?oc=5", "source_name": "Biogen", "published_at": "2023-06-09T07:00:00+00:00", "published_display": "09 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOX01BMWpxUHpWYmFRQTN3U016ZEhjUFQ1UmdDeVR6MHJER0VvNnZIMkw1TXhuWjRaX1JqamxZeFVqeDk1QWgyamFsdUhBb2VpMmhUeWVyQmRIYVNkR2ZOLUpCYU83RXh2U0hhMkhYZy1vS21LSVJncllnZjVXSHd6Mm1EVGZOUDhpNkhveHFyLTZqNHlZYmwtVXBJYWRJQmFnaHdxcW9ZVUFqX3pNSFlBY3RhQVdrZ1pybnNHYUktNUZJQQ?oc=5", "source_name": "Biogen", "published_at": "2022-01-27T08:00:00+00:00", "published_display": "27 Jan 2022 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQQUlSWmZWUV9mYktRV081cXN6c1BRVmxjbXRRSEQ1MTd2SnlCZERDNVFXZGtnQlpMb3B0MHJqRzYtcjVROEczRGRtQUZMMm56TFlQdFVNWnpwVEFuUm9CU1MyUlJvcGR5dHdPQUdjVWIwQmd5d1A3TXQ3dlNabXN2U2VkSGZJMWx2bUt4RHhkWnRPc1ZPeDYydEtlOUplZUg4SEhNd3N5WWk3eXc3M0YtcVl5WHlrM3pOZFN2dHkwaw?oc=5", "source_name": "Biogen", "published_at": "2020-11-27T08:00:00+00:00", "published_display": "27 Nov 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Denali to Collaborate on LRRK2 Program for Parkinson\u2019s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOc0ExWGhSR2pRdzZJU29IcWJvelIwSmRmamM1NFJyMWRKQThhVkVrQXQ1WWpMSHFNSGNKM2lqcmJ0RjkxRzVCNnNIQW1ZZHVWZXA0WEpJTUhwZFFWNzNTN2lneElHYlVYalZuM200WUVELVZiZTJFdEtMd1V3WTZZRERQTlZlRG9neGdXNWl6S0ZhY001Y3cxLXNSQUR4VkFtbVZEMHI3aF9UMGU2Z0hDWE80SmlUOXJrZ0x5OW1sbE9wUi1H?oc=5", "source_name": "Biogen", "published_at": "2020-08-06T07:00:00+00:00", "published_display": "06 Aug 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Board of Directors Approves Separation of Bioverativ and Declares Special Dividend Distribution of Bioverativ Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZXh4dlJwdnhYS3pNay02VWZaYXNqbm1Lamx2NFIxbVhPelI3WVNzeVJJa3RJZU45UllHYUhjMGtqcmgyMUZzZ0pkRzJlVFlOTTl2WVNzcjVfb3JGcnAyWWpSODg4dFUyMmthZU1xMGdJWlAxRWhISzgtZDVIaGRRc1Q0cHhBeHJJYVJURThvQlV0RV8yWmh4QjluN3ZEZnNNeXhvR3BScy1kSnR5UmN0Vk93S3ljek5scmY2ZkV5TQ?oc=5", "source_name": "Biogen", "published_at": "2019-06-12T10:45:37+00:00", "published_display": "12 Jun 2019 10:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Inc (BIIB) Stock Price, Trades & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1ncXJveXZYNmh6cWN1RXNLQXdoNVdoLTluTnhOb0lWbHVVdWZxVWx0OTRkZzVkczRNbFBJUEg1VF85dC1iYVhUazBsVVZfRkV0Q25tenF0RQ?oc=5", "source_name": "GuruFocus", "published_at": "2019-04-15T16:19:17+00:00", "published_display": "15 Apr 2019 16:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Separation of Global Hemophilia Business, Bioverativ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOc1o0UnRZTHRidWIzVGxrNThyZE95WXVtUXVOUVlLT2dQV3hPaG4ta2hzTm1qX1lBZTZyRmRnTmxNaDN6eWdkVExWVVNFMWo2eVZULTdTMHBXUW45Tnd3YkQwdmpJc0VkWUFuRHQ3TzJDNDZJNlZ0Y25HazZVVXludWY0aUgtWWxPQ3h4dWIyNjR0a2V1MTM4RDh0b1JZQW1qU254X0txeDJjZlo3Y0twQXN0dFk4SDVnLWc?oc=5", "source_name": "Biogen", "published_at": "2017-02-01T08:00:00+00:00", "published_display": "01 Feb 2017 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 34, "sentiment_summary": {"positive": 7, "negative": 3, "neutral": 24, "score": 53, "total": 34, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 11.9, "count": 21}, {"event": "deals", "label": "Deals and strategy", "weight": 2.2, "count": 4}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.9, "count": 1}], "positive_events": 7, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 24000.0, "latest_week": "2026-07-10", "one_week_move": -11.4, "four_week_move": 4.5, "twelve_week_move": 20.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.079782, "market_dynamics_buy_signal": false, "relative_strength": -0.545237, "fair_value_gap": 36.7, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.2991, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-11.4% over one week, +4.5% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Biogen", "count": 16}, {"label": "Market source", "count": 7}, {"label": "Barron's", "count": 2}, {"label": "Yahoo! Finance Canada", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Clinical Trials Arena", "count": 1}, {"label": "Investor's Business Daily", "count": 1}, {"label": "Fierce Biotech", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 34}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Deals and strategy", "count": 4}, {"label": "Regulatory and legal", "count": 3}, {"label": "Earnings", "count": 2}, {"label": "Guidance", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "34", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-11.4% over one week, +4.5% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data"}], "updated_at": "2026-07-18T07:06:22.690500+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}